| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8604160 | The American Journal of Medicine | 2017 | 12 Pages |
Abstract
Among patients with symptomatic arthritis who had moderate to high risk of cardiovascular events, approximately 1 in 20 experienced a major toxicity over 1 to 2 years. Patients using naproxen or ibuprofen experienced significantly higher risk of major toxicity than those using celecoxib.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Daniel H. MD, MPH, M. Elaine MD, MPH, Peter A. MD, Neville D. MD, A. Michael MD, Thomas F. MD, Venu MD, Danielle M. MS, Lisa M. RN, Steven E. MD, Jeffrey S. MD,
